5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer

PURPOSE: 5-α reductase inhibitors (5-ARI) have been suggested to increase the risk of male breast cancer. The aim of this study was to study the risk of breast cancer in men on 5-ARI, in men with benign prostatic hyperplasia (BPH) not on 5-ARI, and in men without BPH. METHODS: We performed a populat...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, David, Garmo, Hans, Holmberg, Lars, Stattin, Pär
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540753/
https://www.ncbi.nlm.nih.gov/pubmed/26109464
http://dx.doi.org/10.1007/s10552-015-0622-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540753/
https://www.ncbi.nlm.nih.gov/pubmed/26109464
http://dx.doi.org/10.1007/s10552-015-0622-4

Ejemplares similares